Biomarkers in Exhaled Breath Condensates of Septic Patients to Predict Development of Multi-organ Dysfunction Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01503684|
Recruitment Status : Unknown
Verified September 2011 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted : January 4, 2012
Last Update Posted : January 4, 2012
|Condition or disease||Intervention/treatment|
|Sepsis||Other: Determined by intended physician|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Biomarkers in Exhaled Breath Condensates of Septic Patients to Predict Development of Multi-organ Dysfunction Syndrome|
|Study Start Date :||August 2011|
Patients with sepsis
Patients who are admitted to ICU with the diagnosis of sepsis
Other: Determined by intended physician
We perform a prospective observational study. All the treatment for the patients are determined by intended physicians.
- Development and severity of sepsis [ Time Frame: 28 days ]To record APACHE II, SOFA, and MODS, etc.
- Mortality [ Time Frame: 28 days ]
- Response to treatment and progression of organ failure [ Time Frame: 28 days ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01503684
|Contact: Jih-Shuin Jerng, MD,PhDemail@example.com|
|National Taiwan University Hospital||Recruiting|
|Taipei, Taiwan, 100|
|Contact: Jih-Shuin Jerng, MD, PhD 886-2-23562905 firstname.lastname@example.org|
|Principal Investigator: Jih-Shuin Jerng, MD, PhD|
|Principal Investigator:||Jih-Shuin Jerng, MD, PhD||National Taiwan University Hospital|